Zinc and cancer: implications for LIV-1 in breast cancer
- PMID: 22852056
- PMCID: PMC3407987
- DOI: 10.3390/nu4070648
Zinc and cancer: implications for LIV-1 in breast cancer
Abstract
Zinc is a trace mineral which is vital for the functioning of numerous cellular processes, is critical for growth, and may play an important role in cancer etiology and outcome. The intracellular levels of this mineral are regulated through the coordinated expression of zinc transporters, which modulate both zinc influx as well as efflux. LIV-1 (ZIP6) was first described in 1988 as an estrogen regulated gene with later work suggesting a role for this transporter in cancer growth and metastasis. Despite evidence of its potential utility as a target gene for cancer prognosis and treatment, LIV-1 has received relatively little attention, with only three prior reviews being published on this topic. Herein, the physiological effects of zinc are reviewed in light of this mineral's role in cancer growth with specific attention being given to LIV-1 and the potential importance of this transporter to breast cancer etiology.
Keywords: LIV-1; ZIP6; cancer; zinc; zinc transporters.
Similar articles
-
A mechanism for epithelial-mesenchymal transition and anoikis resistance in breast cancer triggered by zinc channel ZIP6 and STAT3 (signal transducer and activator of transcription 3).Biochem J. 2013 Oct 15;455(2):229-37. doi: 10.1042/BJ20130483. Biochem J. 2013. PMID: 23919497 Free PMC article.
-
Concordant correlation of LIV-1 and E-cadherin expression in human breast cancer cell MCF-7.Mol Biol Rep. 2009 Apr;36(4):653-9. doi: 10.1007/s11033-008-9225-4. Epub 2008 Mar 11. Mol Biol Rep. 2009. PMID: 18330719
-
A distinct role in breast cancer for two LIV-1 family zinc transporters.Biochem Soc Trans. 2008 Dec;36(Pt 6):1247-51. doi: 10.1042/BST0361247. Biochem Soc Trans. 2008. PMID: 19021534
-
The emerging role of the LIV-1 subfamily of zinc transporters in breast cancer.Mol Med. 2007 Jul-Aug;13(7-8):396-406. doi: 10.2119/2007-00040.Taylor. Mol Med. 2007. PMID: 17673939 Free PMC article. Review.
-
Zinc Transporters and the Progression of Breast Cancers.Biol Pharm Bull. 2018;41(10):1517-1522. doi: 10.1248/bpb.b18-00086. Biol Pharm Bull. 2018. PMID: 30270320 Review.
Cited by
-
Micro- and Macronutrients in Endometrial Cancer-From Metallomic Analysis to Improvements in Treatment Strategies.Int J Mol Sci. 2024 Sep 14;25(18):9918. doi: 10.3390/ijms25189918. Int J Mol Sci. 2024. PMID: 39337406 Free PMC article. Review.
-
miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.Oncotarget. 2016 Jan 19;7(3):2672-83. doi: 10.18632/oncotarget.6603. Oncotarget. 2016. PMID: 26684241 Free PMC article.
-
SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma.J Transl Med. 2015 Oct 6;13:321. doi: 10.1186/s12967-015-0681-z. J Transl Med. 2015. PMID: 26444413 Free PMC article.
-
Cysteine-rich intestinal protein 1 silencing alleviates the migration and invasive capability enhancement induced by excessive zinc supplementation in colorectal cancer cells.Am J Transl Res. 2019 Jun 15;11(6):3578-3588. eCollection 2019. Am J Transl Res. 2019. PMID: 31312368 Free PMC article.
-
A Systematic Study on Zinc-Related Metabolism in Breast Cancer.Nutrients. 2023 Mar 31;15(7):1703. doi: 10.3390/nu15071703. Nutrients. 2023. PMID: 37049543 Free PMC article. Review.
References
-
- Stipanuk B.L., Falchuk K.H. Biochemical, Physiological, Molecular Aspects of Human Nutrition. 2nd. Saunders/Elsevier; St. Louis, MO, USA: 1993. pp. 1044–1064.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical